Crescent Capital BDC (NASDAQ:CCAP) Earns Buy Rating from Analysts at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH initiated coverage on shares of Crescent Capital BDC (NASDAQ:CCAPFree Report) in a research report sent to investors on Monday, Marketbeat reports. The firm issued a buy rating and a $20.00 price target on the stock.

CCAP has been the subject of several other research reports. Bank of America reduced their price target on shares of Crescent Capital BDC from $20.00 to $19.00 and set a buy rating for the company in a research report on Thursday, August 15th. Wells Fargo & Company reduced their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an equal weight rating for the company in a research report on Wednesday, August 14th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of Moderate Buy and a consensus target price of $19.00.

Get Our Latest Report on Crescent Capital BDC

Crescent Capital BDC Stock Up 0.2 %

Crescent Capital BDC stock opened at $18.25 on Monday. The company has a quick ratio of 1.40, a current ratio of 1.40 and a debt-to-equity ratio of 1.17. Crescent Capital BDC has a 12-month low of $15.03 and a 12-month high of $19.63. The firm’s fifty day moving average is $18.35 and its 200 day moving average is $18.17. The company has a market capitalization of $676.38 million, a PE ratio of 6.49 and a beta of 0.81.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last released its quarterly earnings data on Monday, August 12th. The company reported $0.59 earnings per share for the quarter, topping the consensus estimate of $0.58 by $0.01. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. The firm had revenue of $48.95 million for the quarter, compared to the consensus estimate of $48.05 million. During the same quarter in the prior year, the company posted $0.56 earnings per share. As a group, sell-side analysts predict that Crescent Capital BDC will post 2.34 EPS for the current fiscal year.

Crescent Capital BDC Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th will be given a dividend of $0.42 per share. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 dividend on an annualized basis and a yield of 9.21%. The ex-dividend date of this dividend is Monday, September 30th. Crescent Capital BDC’s dividend payout ratio (DPR) is presently 59.79%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Point72 Asset Management L.P. bought a new position in shares of Crescent Capital BDC in the second quarter worth approximately $90,000. Tucker Asset Management LLC bought a new stake in Crescent Capital BDC in the fourth quarter valued at $167,000. XTX Topco Ltd bought a new stake in Crescent Capital BDC in the second quarter valued at $195,000. Alpine Global Management LLC bought a new stake in Crescent Capital BDC in the first quarter valued at $217,000. Finally, Catalina Capital Group LLC bought a new stake in Crescent Capital BDC in the second quarter valued at $220,000. Institutional investors own 49.46% of the company’s stock.

Crescent Capital BDC Company Profile

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

See Also

Analyst Recommendations for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.